{"SPADE_UN_13540": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13540", "Peptide Name": "SARS-CoV-2-S(1168–1203)-GSGSGC", "Source": "Synthetic construct", "Family": "Belongs to the betacoronaviruses spike protein family.", "Gene": "S", "Sequence": "DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSGC", "Sequence Length": 42, "UniProt Entry": ["http://www.uniprot.org/uniprot/P0DTC2"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antiviral(SARS-CoV-2)"], "Target Organism": "[Ref.33082259]Virus:SARS-CoV-2:ihibition of cell-cell fusion in 293T cells(IC50=10±8 nM,IC90=98±57 nM),inhibition of infection in Vero E6 cells(IC50~ 6 nM);SARS-CoV-2_D614G:ihibition of cell-cell fusion in 293T cells(IC50=8±4 nM,IC90=96±50 nM);SARS-CoV-2_S943P:ihibition of cell-cell fusion in 293T cells(IC50=6±4 nM,IC90=75±42 nM);SARS-CoV-2_S247R:ihibition of cell-cell fusion in 293T cells(IC50=9±7 nM,IC90=78±59 nM);MERS-CoV:ihibition of cell-cell fusion in 293T cells(IC50=35±10 nM,IC90>1000 nM),inhibition of infection in Vero E6 cells(IC50~ 3 nM);SARS-CoV-1:ihibition of cell-cell fusion in 293T cells(IC50=7±5 nM,IC90=43±6 nM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "[Ref.33082259]Human embryonic kidney HEK293T cells:18% Cytotoxicity at 10 µM;Vero E6 cells:12% Cytotoxicity at 1 µM,30% Cytotoxicity at 10 µM;Human airway epithelial cells:25% Cytotoxicity at 1 µM.", "Binding Target": "liposomes", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C187H316N54O69S", "Mass": 4456.89, "PI": 4.2, "Net Charge": -4, "Hydrophobicity": -0.16, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:>10 hour", "Mechanism of action": "The lipopeptide is derived from the C-terminal heptad repeat (HRC) domain of SARS-CoV-2 S that potently inhibits infection by SARS-CoV-2.", "Literature": [{"Title": "Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.", "Pubmed ID": "33082259", "Reference": "mBio. 2020 Oct 20;11(5)e01935-20.", "Author": "Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, Porotto M.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33082259"}, {"Title": "Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.", "Pubmed ID": "33597220", "Reference": "Science. 2021 Mar 26;371(6536)1379-1382.", "Author": "de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, Haagmans BL, Herfst S, Stearns KN, Drew-Bear J, Biswas S, Rockx B, McGill G, Dorrello NV, Gellman SH, Alabi CA, de Swart RL, Moscona A, Porotto M.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33597220"}], "Frequent Amino Acids": "ILN", "Absent Amino Acids": "FHMOPTUWY", "Basic Residues": 3, "Acidic Residues": 7, "Hydrophobic Residues": 15, "Polar Residues": 21, "Positive Residues": 3, "Negative Residues": 7, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13518", "Similarity": 1.0, "Sequence": "DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL"}, {"SPADE_ID": "SPADE_UN_13829", "Similarity": 1.0, "Sequence": "GDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELG"}, {"SPADE_ID": "SPADE_UN_14886", "Similarity": 1.0, "Sequence": "ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL"}]}}}